Publication: Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Afşar, Barış
Afşar, Rengin Elsürer
Sag, Alan A.
Kanbay, Asiye
Korkmaz, Hakan
Cipolla-Neto, José
Covic, Adrian
Ortiz, Alberto
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Melatonin is the main biochronologic molecular mediator of circadian rhythm and sleep. It is also a powerful antioxidant and has roles in other physiologic pathways. Melatonin deficiency is associated with metabolic derangements including glucose and cholesterol dysregulation, hypertension, disordered sleep and even cancer, likely due to altered immunity. Diabetic nephropathy (DN) is a key microvascular complication of both type 1 and 2 diabetes. DN is the end result of a complex combination of metabolic, haemodynamic, oxidative and inflammatory factors. Interestingly, these same factors have been linked to melatonin deficiency. This report will collate in a clinician-oriented fashion the mechanistic link between melatonin deficiency and factors contributing to DN.
Source
Publisher
Oxford University Press
Subject
Citation
item.page.haspartof
Source
Clinical Kidney Journal
item.page.ispartofseries
item.page.edition
DOI
10.1093/CKJ/SFZ198
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A
